Education
About Us
Working with TipRanks
Follow Us
Raf Souccar Insider Profile
4 Followers
Raf Souccar, Director at Aleafia Health, holds 2.19M shares in Origin Therapeutics Holdings, Inc. (Ticker: TSE:SPLY), holds 4.51M shares in Aleafia Health (Ticker: ALEAF). Most recently, Raf Souccar Bought ― shares of Origin Therapeutics Holdings, Inc. on Dec 23, 2025 for an estimated value of C$25.43K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+4.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Raf Souccar holds in companies
Most Profitable Insider Trade
Stock:
Aleafia Health
(ALEAF)
(ALEAF)
Rating:Informative Buy
Date:Mar 30, 2020 - Mar 30, 2021
Return:+73.30%
The most profitable trade made by Raf Souccar
Raf Souccar's Trading History
Aleafia Health
Mar 30, 2020
―
Informative Buy
3.51K
$67.65K
Origin Therapeutics Holdings, Inc.
Dec 23, 2025
Director
Informative Buy
25.43K
C$87.46K
List of latest transactions for each holding click on a transaction to see Raf Souccar's performance on stock
You May Also Like
Raf Souccar insider profile FAQ
What is the percentage of profitable transactions made by Raf Souccar?
The percentage of profitable transactions made by Raf Souccar is 33%.
What is the average return per transaction made by Raf Souccar?
The average return per transaction made by Raf Souccar is 4.40%.
What stocks does Raf Souccar hold?
Raf Souccar holds: ALEAF, TSE:SPLY stocks.
What was Raf Souccar’s latest transaction?
Raf Souccar latest transaction was an Informative Buy of C$25.43K.
What was Raf Souccar's most profitable transaction?
Raf Souccar’s most profitable transaction was an Informative Buy of ALEAF stock on March 30, 2020. The return on the trade was 73.30%.
What is Raf Souccar's role in Aleafia Health?
Raf Souccar's role in Aleafia Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.